CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Losses	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		97,209,213
Beginning balance at Dec. 31, 2022	$ 316,270	$ 2	$ 609,849	$ (384)	$ (293,197)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		18,596
Issuance of common stock upon exercise of stock options	68		68
Stock-based compensation expense	1,681		1,681
Change in unrealized loss on investments, net of tax	179			179
Net loss	(39,397)				(39,397)
Ending balance (in shares) at Mar. 31, 2023		97,227,809
Ending balance at Mar. 31, 2023	278,801	$ 2	611,598	(205)	(332,594)
Beginning balance (in shares) at Dec. 31, 2022		97,209,213
Beginning balance at Dec. 31, 2022	316,270	$ 2	609,849	(384)	(293,197)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized loss on investments, net of tax	116
Net loss	(81,782)
Ending balance (in shares) at Jun. 30, 2023		97,269,915
Ending balance at Jun. 30, 2023	240,102	$ 2	615,347	(268)	(374,979)
Beginning balance (in shares) at Mar. 31, 2023		97,227,809
Beginning balance at Mar. 31, 2023	278,801	$ 2	611,598	(205)	(332,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		42,106
Issuance of common stock upon exercise of stock options	166		166
Stock-based compensation expense	3,583		3,583
Change in unrealized loss on investments, net of tax	(63)			(63)
Net loss	(42,385)				(42,385)
Ending balance (in shares) at Jun. 30, 2023		97,269,915
Ending balance at Jun. 30, 2023	$ 240,102	$ 2	615,347	(268)	(374,979)
Beginning balance (in shares) at Dec. 31, 2023	97,377,121	97,377,121
Beginning balance at Dec. 31, 2023	$ 133,071	$ 2	624,414	(15)	(491,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from public offering, net of issuance costs of $8.9 million (in shares)		22,560,001
Issuance of common stock from public offering, net of issuance costs of $8.9 million	132,055	$ 0	132,055
Issuance of pre-funded warrants, net of issuance costs of $1.2 million	18,800		18,800
Issuances of common under ESPP (in shares)		74,488
Issuances of common under ESPP	436		436
Issuance of common stock upon exercise of stock options (in shares)		9,664
Issuance of common stock upon exercise of stock options	36		36
Stock-based compensation expense	5,209		5,209
Change in unrealized loss on investments, net of tax	(80)			(80)
Net loss	(45,761)				(45,761)
Ending balance (in shares) at Mar. 31, 2024		120,021,274
Ending balance at Mar. 31, 2024	$ 243,766	$ 2	780,950	(95)	(537,091)
Beginning balance (in shares) at Dec. 31, 2023	97,377,121	97,377,121
Beginning balance at Dec. 31, 2023	$ 133,071	$ 2	624,414	(15)	(491,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	19,203
Change in unrealized loss on investments, net of tax	$ (56)
Net loss	$ (101,088)
Ending balance (in shares) at Jun. 30, 2024	120,030,813	120,030,813
Ending balance at Jun. 30, 2024	$ 196,589	$ 2	789,076	(71)	(592,418)
Beginning balance (in shares) at Mar. 31, 2024		120,021,274
Beginning balance at Mar. 31, 2024	243,766	$ 2	780,950	(95)	(537,091)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		9,539
Issuance of common stock upon exercise of stock options	35		35
Stock-based compensation expense	8,091		8,091
Change in unrealized loss on investments, net of tax	24			24
Net loss	$ (55,327)				(55,327)
Ending balance (in shares) at Jun. 30, 2024	120,030,813	120,030,813
Ending balance at Jun. 30, 2024	$ 196,589	$ 2	$ 789,076	$ (71)	$ (592,418)